Literature DB >> 12023412

Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

B H Wood1, J A Bilclough, A Bowron, R W Walker.   

Abstract

OBJECTIVES: To accurately establish the incidence of falls in Parkinson's disease (PD) and to investigate predictive risk factors for fallers from baseline data.
METHODS: 109 subjects with idiopathic PD diagnosed according to the brain bank criteria underwent a multidisciplinary baseline assessment comprising demographic and historical data, disease specific rating scales, physiotherapy assessment, tests of visual, cardiovascular and autonomic function, and bone densitometry. Patients were then prospectively followed up for one year using weekly prepaid postcards along with telephone follow up.
RESULTS: Falls occurred in 68.3% of the subjects. Previous falls, disease duration, dementia, and loss of arm swing were independent predictors of falling. There were also significant associations between disease severity, balance impairment, depression, and falling.
CONCLUSIONS: Falls are a common problem in PD and some of the major risk factors are potentially modifiable. There is a need for future studies to look at interventions to prevent falls in PD.

Entities:  

Mesh:

Year:  2002        PMID: 12023412      PMCID: PMC1737913          DOI: 10.1136/jnnp.72.6.721

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  38 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Fall risk factors in Parkinson's disease.

Authors:  P Gray; K Hildebrand
Journal:  J Neurosci Nurs       Date:  2000-08       Impact factor: 1.230

3.  A community-dwelling sample of people with Parkinson's disease: characteristics of fallers and non-fallers.

Authors:  A Ashburn; E Stack; R M Pickering; C D Ward
Journal:  Age Ageing       Date:  2001-01       Impact factor: 10.668

4.  Prospective assessment of falls in Parkinson's disease.

Authors:  B R Bloem; Y A Grimbergen; M Cramer; M Willemsen; A H Zwinderman
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

Review 5.  Diagnosis and management of diabetic autonomic neuropathy.

Authors:  D J Ewing; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-02

6.  Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition.

Authors:  C Sachs; B Berglund; L Kaijser
Journal:  Acta Neurol Scand       Date:  1985-01       Impact factor: 3.209

7.  Avoiding mental changes and falls in older Parkinson's patients.

Authors:  G W Paulson; K Schafer; B Hallum
Journal:  Geriatrics       Date:  1986-08

8.  Hip fractures in patients with Parkinson's disease.

Authors:  L Coughlin; J Templeton
Journal:  Clin Orthop Relat Res       Date:  1980-05       Impact factor: 4.176

9.  Fall risk index for elderly patients based on number of chronic disabilities.

Authors:  M E Tinetti; T F Williams; R Mayewski
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

10.  Forgetting falls. The limited accuracy of recall of falls in the elderly.

Authors:  S R Cummings; M C Nevitt; S Kidd
Journal:  J Am Geriatr Soc       Date:  1988-07       Impact factor: 5.562

View more
  164 in total

1.  Fluorometric assay for N-acetylprocainamide.

Authors:  E Matusik; T P Gibson
Journal:  Clin Chem       Date:  1975-12       Impact factor: 8.327

2.  Utility of the Mini-BESTest, BESTest, and BESTest sections for balance assessments in individuals with Parkinson disease.

Authors:  Abigail L Leddy; Beth E Crowner; Gammon M Earhart
Journal:  J Neurol Phys Ther       Date:  2011-06       Impact factor: 3.649

3.  Neurologist care in Parkinson disease: a utilization, outcomes, and survival study.

Authors:  A W Willis; M Schootman; B A Evanoff; J S Perlmutter; B A Racette
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

4.  Functional gait assessment and balance evaluation system test: reliability, validity, sensitivity, and specificity for identifying individuals with Parkinson disease who fall.

Authors:  Abigail L Leddy; Beth E Crowner; Gammon M Earhart
Journal:  Phys Ther       Date:  2010-11-11

Review 5.  Use of a physiological profile to document motor impairment in ageing and in clinical groups.

Authors:  S R Lord; K Delbaere; S C Gandevia
Journal:  J Physiol       Date:  2015-12-07       Impact factor: 5.182

Review 6.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

7.  Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period.

Authors:  Lisa-Ann Fraser; Jonathan D Adachi; William D Leslie; David Goltzman; Robert Josse; Jerilynn Prior; Stephanie Kaiser; Nancy Kreiger; Christopher S Kovacs; Tassos P Anastassiades; Alexandra Papaioannou
Journal:  Ann Pharmacother       Date:  2014-05-09       Impact factor: 3.154

8.  The Mini-BESTest is an independent predictor of falls in Parkinson Disease.

Authors:  Larissa Karlla Rodrigues Lopes; Aline Alvim Scianni; Lidiane Oliveira Lima; Raquel de Carvalho Lana; Fátima Rodrigues-De-Paula
Journal:  Braz J Phys Ther       Date:  2019-07-25       Impact factor: 3.377

Review 9.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

10.  Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.

Authors:  Thomas Gerald Beach; Charles H Adler; Lucia I Sue; Jeffrey B Peirce; Jyothi Bachalakuri; Jessica E Dalsing-Hernandez; Lih Fen Lue; John N Caviness; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.